BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29394806)

  • 1. [A Case of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern].
    Sekiya M; Sakamoto K; Matsukuma S; Tokuhisa Y; Tokumitsu Y; Matsui H; Kanekiyo S; Tomochika S; Iida M; Takeda S; Suzuki N; Yoshino S; Hazama S; Hoshii Y; Nagano H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1877-1879. PubMed ID: 29394806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):737-48. PubMed ID: 23573322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
    Huang B; Wu L; Lu XY; Xu F; Liu CF; Shen WF; Jia NY; Cheng HY; Yang YF; Shen F
    Radiology; 2016 Oct; 281(1):150-7. PubMed ID: 27077381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
    Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
    J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics.
    Nanashima A; Abo T; Murakami G; Matsumoto A; Tou K; Takeshita H; Kunizaki M; Hidaka S; Sakamoto I; Hayashi H; Fukuda T; Kudo T; Nagayasu T
    Abdom Imaging; 2013 Aug; 38(4):785-92. PubMed ID: 23232581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of concomitant colitic cancer and intrahepatic cholangiocarcinoma during follow-up for ulcerative colitis.
    Tsuchiya K; Nanashima A; Ikeda T; Minami S; Nagano M; Hamada T; Yano K; Fujii Y
    Clin J Gastroenterol; 2017 Apr; 10(2):157-162. PubMed ID: 28138905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinicopathological characteristics between patients with occupational and non-occupational intrahepatic cholangiocarcinoma.
    Hamano G; Kubo S; Takemura S; Tanaka S; Shinkawa H; Kinoshita M; Ito T; Yamamoto T; Wakasa K; Shibata T
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):389-96. PubMed ID: 27062258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
    Lu Q; Xue LY; Wang WP; Huang BJ; Li CX
    Abdom Imaging; 2015 Aug; 40(6):1558-66. PubMed ID: 25725793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma.
    Bhalla A; Mann SA; Chen S; Cummings OW; Lin J
    Hum Pathol; 2017 Sep; 67():217-224. PubMed ID: 28823571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hilar bile duct cancer associated with preoperatively undetectable von Meyenburg complex--report of a case.
    Eguchi S; Tajima Y; Yanaga K; Okudaira S; Furui J; Hayashi T; Kanematsu T
    Hepatogastroenterology; 2004; 51(59):1301-3. PubMed ID: 15362738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of intrahepatic cholangiocarcinoma arising from a simple hepatic cyst via dysplasia and carcinomatous transformation.
    Tanimura I; Yoneda N; Kitao A; Nio K; Kaneko S; Okazaki M; Ikeda H; Kobayashi S; Gabata T
    Abdom Radiol (NY); 2022 Jun; 47(6):1954-1960. PubMed ID: 35347383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
    Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
    Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
    Seo N; Kim DY; Choi JY
    AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.